Table 1.
Clinical, biological, and arterial characteristics of the 180 patients
| Parameters | Mean | (SD) |
|---|---|---|
| Age (years) | 59.6 | (14.2) |
| Gender (F/M) | 47/133 | |
| Body mass index (kg/m2) | 25.7 | (4.7) |
| Hypertension, n (%) | 164 (91%) | |
| Tabacco, current n (%) | 29 (16%) | |
| Dyslipidemia, n (%) | 122 (68%) | |
| Diabetes, n (%) | 25 (14%) | |
| Previous CV event, n (%) | 51 (29%) | |
| ACEi, n (%) | 103 (57%) | |
| ARB, n (%) | 110 (61%) | |
| Dual blockade, n (%) | 61 (34%) | |
| ACEi or ARB, n (%) | 152 (74%) | |
| Calcium channel blockers, n (%) | 96 (53%) | |
| β blockers, n (%) | 70 (39%) | |
| Diuretics, n (%) | 70 (39%) | |
| Nb anti-hypertensive drugs | 2.5 | (1.3) |
| Statins, n (%) | 104 (58%) | |
| Erythropietin, n (%) | 17 (9%) | |
| Alfacalcidol, n (%) | 44 (25%) | |
| Calcium supplementation, n (%) | 31 (17%) | |
| Mean follow-up (years) | 3.1 | (0.3) |
| Slope mGFR, (ml/min per 1.73 m2 per year) | −1.7 | (3.7) |
| Dialysis during follow-up, n (%) | 41 (27%) | |
| Death, n (%) | 10 (6%) | |
| Brachial BP | ||
| systolic BP (mmHg) | 134 | (22) |
| mean BP (mmHg) | 94 | (13) |
| diastolic BP (mmHg) | 74 | (10) |
| Heart rate (bpm) | 65 | (11) |
| Biological parameters | ||
| measured GFR (ml/min per 1.73 m2) | 32 | (16) |
| creatinine (μmol/L) | 224 | (113) |
| UACR (mg/mmol) | 19.8 | (70)a |
| HbA1C (%) | 5.6 | (1.08) |
| total cholesterol (mmol/L) | 4.8 | (1.13) |
| HDL cholesterol (mmol/L) | 1.15 | (0.4) |
| LDL cholesterol (mmol/L) | 2.9 | (1.02) |
| triglycerides (mmol/L) | 1.5 | (0.84) |
ACEi, angiotensinogen converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CV, cardiovascular; UACR, urinary albumin creatinine ratio.
aMedian (interquartile range).